Carbonic anhydrase inhibitors. Inhibition of human tumor-associated isozymes IX and cytosolic isozymes I and II with some 1,3,4-oxadiazole-thiols

Journal of Enzyme Inhibition and Medicinal Chemistry

Volumn 21, Issue 4, 2006, Pages 351-359

  Zareef, Muhammad ^a   Innocenti, Alessio ^b   Iqbal, Rashid ^a   Zaidi, Javid H ^a   Arfan, Muhammad ^a   Scozzafava, Andrea ^b   Supuran, Claudiu T ^b  

^a QUAID I AZAM UNIVERSITY   (Pakistan)

^b UNIVERSITY OF FLORENCE   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

1,3,4 OXADIAZOLE DERIVATIVE; ACETAZOLAMIDE; AMINO ACID; BENZENE; CARBON DISULFIDE; CARBONATE DEHYDRATASE; CARBONATE DEHYDRATASE I; CARBONATE DEHYDRATASE II; CARBONATE DEHYDRATASE INHIBITOR; CARBONATE DEHYDRATASE IX; DICLOFENAMIDE; ESTER; ETHOXZOLAMIDE; HETEROCYCLIC COMPOUND; HYDRAZIDE; INDISULAM; ISOENZYME; METHAZOLAMIDE; SULFONAMIDE; THIOL DERIVATIVE;

ARTICLE; BINDING AFFINITY; CHIRALITY; CYCLIZATION; DRUG STRUCTURE; ENZYME INHIBITION; PRIORITY JOURNAL;

ANTINEOPLASTIC AGENTS; CARBONIC ANHYDRASE I; CARBONIC ANHYDRASE II; CARBONIC ANHYDRASE INHIBITORS; CATALYTIC DOMAIN; DRUG DESIGN; HUMANS; MODELS, CHEMICAL; NEOPLASMS; PROTEIN ISOFORMS; SPECTROSCOPY, FOURIER TRANSFORM INFRARED; SULFHYDRYL COMPOUNDS;

EID: 33748486453     PISSN: 14756366     EISSN: 14756374     Source Type: Journal    
DOI: 10.1080/14756360600741503     Document Type: Article

References (43)

1. Supuran, CT and Scozzafava, A and Conway, J. (2004) Carbonic anhydrase. Its inhibitors and activators. London: CRC Press.
2. Supuran, CT and Scozzafava, A and Casini, A. (2003) Carbonic anhydrase inhibitors Med Res Rev, 23, pp. 146-189.
3. Supuran, CT and Scozzafava, A. (2000) Carbonic anhydrase inhibitors and their therapeutic potential Exp Opin Ther Patents, 10, pp. 575-600.
4. Supuran, CT. (2004) Carbonic anhydrases: Catalytic and inhibition mechanisms, distribution and physiological roles. In carbonic anhydrase. Its inhibitors and activators. (pp. 1-23). London: CRC Press.
5. Pastorekova, S and Parkkila, S and Pastorek, J and Supuran, CT. (2004) Carbonic anhydrases: Current state of the art, therapeutic applications and future prospects J Enz Inhib Med Chem, 19, pp. 199-229.
6. Scozzafava, A and Mastrolorenzo, A and Supuran, CT. (2004) Modulation of carbonic anhydrase activity and its applications in therapy Expert Opin Ther Pat, 14, pp. 667-702.
7. Pastoreková, S and Pastorek, J.(2004) Cancer-related carbonic anhydrase isozymes and their inhibition. In Carbonic anhydrase. Its inhibitors and activators. (pp. 255-281). London: CRC Press.
8. Pastorekova, S and Zavadova, Z and Kostal, M and Babusikova, O and Zavada, J. (1992) A novel quasi-viral agent, MaTu, is a two-component system Virology, 187, pp. 620-626.
9. Zavada, J and Zavadova, Z and Pastorekova, S and Ciampor, F and Pastorek, J and Zelnik, V. (1993) Expression of MaTu-MN protein in human tumor cultures and in clinical specimens Int. J. Cancer, 54, pp. 268-274.
10. Zavada, J and Zavadova, Z and Pastorek, J and Biesova, Z and Jezek, J and Velek, J. (2000) Human tumour-associated cell adhesion protein MN/CA IX: Identification of M75 epitope and of the region mediating cell adhesion Br. J. Cancer, 82, pp. 1808-1813.
11. Stubbs, M and McSheehy, PM and Griffiths, JR and Bashford, CL. (2000) Causes and consequences of tumour acidity and implications for treatment Mol Med Today, 6, pp. 15-19.
12. Potter, CPS and Harris, AL. (2003) Diagnostics, prognostics and therapeutic implications of carbonic anhydrases in cancer Brit J Cancer, 89, pp. 2-7.
13. Supuran, CT and Casini, A and Scozzafava, A.(2004) Development of carbonic anhydrase inhibitors. In Carbonic anhydrase. Its inhibitors and activators. (pp. 67-147). London: CRC Press.
14. Krungkrai, J and Scozzafava, A and Reungprapavut, S and Krungkrai, SR and Rattanajak, R and Kamchonwongpaisan, S and Supuran, CT. (2005) Carbonic anhydrase inhibitors. Inhibition of Plasmodium falciparum carbonic anhydrase with aromatic sulfonamides: Towards antimalarials with a novel mechanism of action? Bioorg Med Chem, 13, pp. 483-489.
15. Suarez Covarrubias, A and Larsson, AM and Hogbom, M and Lindberg, J and Bergfors, T and Bjorkelid, C and Mowbray, SL and Unge, T and Jones, TA. (2005) Structure and function of carbonic anhydrases from Mycobacterium tuberculosis J Biol Chem, 280, pp. 18782-18789.
16. Suarez Covarrubias, A and Bergfors, T and Jones, TA and Hogbom, M. (2006) Structural mechanics of the pH dependent activity of beta -carbonic anhydrase from Mycobacterium tuberculosis J. Biol. Chem. in press
17. 2 sensing with cAMP signaling and virulence Curr Biol, 15, pp. 2021-2026.
18. 2 sensing during Cryptococcus neoformans growth, differentiation, and virulence Curr Biol, 15, pp. 2013-2020.
19. Svastova, E and Hulikova, A and Rafajova, M and Zat'ovicova, M and Gibadulinova, A and Casini, A and Cecchi, A and Scozzafava, A and Supuran, CT and Pastorek, J and Pastorekova, S. (2004) Hypoxia activates the capacity of tumor-associated carbonic anhydrase IX to acidify extracellular pH FEBS Lett., 577, pp. 439-445.
20. Cecchi, A and Hulikova, A and Pastorek, J and Pastorekova, S and Scozzafava, A and Winum, J-Y and Montero, J-L and Supuran, CT. (2005) Carbonic anhydrase inhibitors. Sulfonamides inhibit isozyme IX mediated acidification of hypoxic tumors. Fluorescent sulfonamides design as probes of membrane-bound carbonic anhydrase isozymes involvement in tumorigenesis J Med Chem, 48, pp. 4834-4841.
21. Wykoff, CC and Beasley, NJ and Watson, PH and Turner, KJ and Pastorek, J and Sibtain, A and Wilson, GD and Turley, H and Talks, KL and Maxwell, PH and Pugh, CW and Ratcliffe, PJ and Harris, AL. (2000) Hypoxia-inducible expression of tumor-associated carbonic anhydrases Cancer Res, 60, pp. 7075-7083.
22. Pastorekova, S and Casini, A and Scozzafava, A and Vullo, D and Pastorek, J and Supuran, CT. (2004) Carbonic anhydrase inhibitors: The first selective, membrane-impermeant inhibitors targeting the tumor-associated isozyme IX Bioorg Med Chem Let, 14, pp. 869-873.
23. Vullo, D and Innocenti, A and Nishimori, I and Pastorek, J and Scozzafava, A and Pastorekova, S and Supuran, CT. (2005) Carbonic anhydrase inhibitors. Inhibition of the transmembrane isozyme XII with sulfonamides-a new target for the design of antitumor and antiglaucoma drugs? Bioorg Med Chem Lett, 15, pp. 963-969.
24. Casey, JR and Morgan, PE and Vullo, D and Scozzafava, A and Mastrolorenzo, A and Supuran, CT. (2004) Carbonic anhydrase inhibitors. Design of selective, membrane-impermeant inhibitors targeting the human tumor-associated isozyme IX J Med Chem, 47, pp. 2337-2347.
25. Supuran, CT and Scozzafava, A. (2000) Carbonic anhydrase inhibitors: Aromatic sulfonamides and disulfonamides act as efficient tumor growth inhibitors J Enz Inhib, 15, pp. 597-610.
26. Abbate, F and Casini, A and Scozzafava, A and Supuran, CT. (2003) Carbonic anhydrase inhibitors: X ray crystallographic structure of the adduct of human isozyme II with the perfluorobenzoyl analogue of methazolamide. Implications for the drug design of fluorinated inhibitors J Enz Inhib Med Chem, 18, pp. 303-308.
27. Abbate, F and Casini, A and Owa, T and Scozzafava, A and Supuran, CT. (2004) Carbonic anhydrase inhibitors: E7070, a sulfonamide anticancer agent, potently inhibits cytosolic isozymes I and II, and transmembrane, tumor-associated isozyme IX Bioorg Med Chem Lett, 14, pp. 217-223.
28. Weber, A and Casini, A and Heine, A and Kuhn, D and Supuran, CT and Scozzafava, A and Klebe, G. (2004) Unexpected nanomolar inhibition of carbonic anhydrase by COX-2 selective Celecoxib: New pharmacological opportunities due to related binding site recognition J Med Chem, 47, pp. 550-557.
29. Scozzafava, A and Briganti, F and Ilies, M and Supuran, CT. (2000) Carbonic anhydrase inhibitors: Synthesis of membrane-impermeant low molecular weight sulfinamides possessing in vivo selectivity for the membrane-bound versus cytosolic isozymes J Med Chem, 43, pp. 292-300.
30. Vullo, D and Franchi, M and Gallori, E and Pastorek, J and Scozzafava, A and Pastorekova, S and Supuran, CT. (2003) Carbonic anhydrase inhibitors. Inhibition of the tumor-associated isozyme IX with aromatic and heterocyclic sulfonamides Bioorg Med Chem Lett, 13, pp. 1005-1009.
31. Innocenti, A and Casini, A and Alcaro, AC and Papini, AM and Scozzafava, A and Supuran, CT. (2004) Carbonic anhydrase inhibitors: The first on-resin screening of a 4-sulfamoylphenylthiourea library J Med Chem, 47, pp. 5224-5229.
32. Khalifah, RG. (1971) The carbon dioxide hydration activity of carbonic anhydrase. I. Stop-flow kinetic studies on the native human isoenzymes B and C J Biol Chem, 246, pp. 2561-2573.
33. Ladva, K and Patel, P and Upadhyay, P and Parekh, H. (1996) Synthesis and biological activities of substituted 1,3,4-oxadiazole derivatives Ind. J Chem, 35B, pp. 1062.
34. Lai, JYQ and Ferguson, Y and Jones, M. (2003) Preparation of substituted quinolinyl and isoquinolinyl sulfonyl chlorides for synthesis of novel sulfonamides Synth. Commun., 33, pp. 3427.
35. Furniss, BS and Hannaford, AJ and Rogers, V and Smith, PWG and Tatchell, AR. Vogel Textbook of Practical Organic Chemistry 4th ed. London: LongmPPn. a: Pp 1135; b: pp 505; c: pp 1242
36. Sun, XW and Liang, HT and Zhang, ZY. (1999) Synthesis and antibacterial activity of 4-aryl-1-(1-p-chlorophenyl-5-methyl-1,2,3-triazol- 4-carbonyl)thiosemicarbazides and their related heterocyclic derivatives. Ind. J Chem 1999;38B:679.
37. Clare, BW and Scozzafava, A and Supuran, CT. (2001) Protease inhibitors. Synthesis of a series of bacterial collagenase inhibitors of the sulfonyl amino acyl hydroxamate type J Med Chem, 44, pp. 2253-2258.
38. Ahmad, R and Iqbal, R and Akhtar, RH and Haq, ZU and Duddeck, H and Stefaniak, L and Sitkowski, J. (2001) Synthesis and structure determination of some oxadiazole-2-thione and triazole-3-thione galactosides Nucleosides, Nucleotides and Nucleic Acids, 20, pp. 1671.
39. Yousif, MY and Ismail, AM and Elman, AA and El-Kerdawy, MM. (1986) Synthesis of substituted Mercapto-1,2,4-triazoles and substituted 1,2,4-triazoles-5-ylmercaptomethyl-1,3,4-oxadiazoles as Antimicrobal Agents J Chem Soc Pak, 8, pp. 183.
40. Iqbal, R and Zareef, M and Zaidi, JH and Khan, KM and Arfan, M and Masoudi, NA. (submitted) Synthesis, anti- HIV and anti-fungal activities of novel chiral and achiral sulfonamides bearing 1,3,4-oxadiazol-2-ylthio moiety J Heterocyclic Chem.
41. Supuran, CT and Scozzafava, A and Saramet, I and Banciu, MD. (1998) Carbonic anhydrase inhibitors. Inhibition of isozymes I, II and IV with heterocyclic mercaptans, sulfenamides, sulfonamides and their metal complexes J Enz Inhib, 13, pp. 177-194.
42. Scozzafava, A and Saramet, I and Banciu, MD and Supuran, CT. (2001) Carbonic anhydrase activity modulators: Synthesis of inhibitors and activators incorporating 2-subtituted-thiazol-4-yl-methyl scaffolds J Enz Inhib, 16, pp. 351-358.
43. Almajan, GL and Innocenti, A and Puccetti, L and Manole, G and Barbuceanu, S and Saramet, I and Scozzafava, A and Supuran, CT. (2005) Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols Biorg Med Chem Lett, 15, pp. 2347-2352.